63 related articles for article (PubMed ID: 23551598)
1. Bioinformatics analysis reveals potential candidate drugs for cervical cancer.
Ai Z; Wang J; Xu Y; Teng Y
J Obstet Gynaecol Res; 2013 May; 39(5):1052-8. PubMed ID: 23551598
[TBL] [Abstract][Full Text] [Related]
2. Network motifs in the transcriptional regulation network of cervical carcinoma cells respond to EGF.
Wu SF; Qian WY; Zhang JW; Yang YB; Liu Y; Dong Y; Zhang ZB; Zhu YP; Feng YJ
Arch Gynecol Obstet; 2013 Apr; 287(4):771-7. PubMed ID: 23188118
[TBL] [Abstract][Full Text] [Related]
3. Terrein induces apoptosis in HeLa human cervical carcinoma cells through p53 and ERK regulation.
Porameesanaporn Y; Uthaisang-Tanechpongtamb W; Jarintanan F; Jongrungruangchok S; Thanomsub Wongsatayanon B
Oncol Rep; 2013 Apr; 29(4):1600-8. PubMed ID: 23417151
[TBL] [Abstract][Full Text] [Related]
4. A computational bioinformatics analysis of gene expression identifies candidate agents for prostate cancer.
Wen DY; Geng J; Li W; Guo CC; Zheng JH
Andrologia; 2014 Aug; 46(6):625-32. PubMed ID: 23790256
[TBL] [Abstract][Full Text] [Related]
5. EGF upregulates Na+/H+ exchanger NHE1 by post-translational regulation that is important for cervical cancer cell invasiveness.
Chiang Y; Chou CY; Hsu KF; Huang YF; Shen MR
J Cell Physiol; 2008 Mar; 214(3):810-9. PubMed ID: 17894388
[TBL] [Abstract][Full Text] [Related]
6. Crude phenolic extracts from extra virgin olive oil circumvent de novo breast cancer resistance to HER1/HER2-targeting drugs by inducing GADD45-sensed cellular stress, G2/M arrest and hyperacetylation of Histone H3.
Oliveras-Ferraros C; Fernández-Arroyo S; Vazquez-Martin A; Lozano-Sánchez J; Cufí S; Joven J; Micol V; Fernández-Gutiérrez A; Segura-Carretero A; Menendez JA
Int J Oncol; 2011 Jun; 38(6):1533-47. PubMed ID: 21455577
[TBL] [Abstract][Full Text] [Related]
7. Identification of pathways involved in paclitaxel activity in cervical cancer.
Qiao WJ; Cheng HY; Li CQ; Jin H; Yang SS; Li X; Zhang YY
Asian Pac J Cancer Prev; 2011; 12(1):99-102. PubMed ID: 21517239
[TBL] [Abstract][Full Text] [Related]
8. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
Sreekanth CN; Bava SV; Sreekumar E; Anto RJ
Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920
[TBL] [Abstract][Full Text] [Related]
9. [Screening for cervical cancer-related genes and their bioinformatics analysis].
Chen SZ; Ma WL; Zheng WL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):585-8. PubMed ID: 18495597
[TBL] [Abstract][Full Text] [Related]
10. Substantial changes in gene expression of Wnt, MAPK and TNFalpha pathways induced by TGF-beta1 in cervical cancer cell lines.
Kloth JN; Fleuren GJ; Oosting J; de Menezes RX; Eilers PH; Kenter GG; Gorter A
Carcinogenesis; 2005 Sep; 26(9):1493-502. PubMed ID: 15878915
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells.
Steller MA; Delgado CH; Bartels CJ; Woodworth CD; Zou Z
Cancer Res; 1996 Apr; 56(8):1761-5. PubMed ID: 8620490
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
Tuck AB; Hota C; Wilson SM; Chambers AF
Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
[TBL] [Abstract][Full Text] [Related]
13. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
Shehata M; Shehata M; Shehata F; Pater A
Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
[TBL] [Abstract][Full Text] [Related]
14. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
Yin F; Giuliano AE; Law RE; Van Herle AJ
Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of ICI 182,780 on the cytotoxicity of cisplatin in cervical carcinoma cell lines.
García-López P; Rodríguez-Dorantes M; Pérez-Cárdenas E; Cerbón M; Mohar-Betancourt A
Cancer Chemother Pharmacol; 2004 Jun; 53(6):533-40. PubMed ID: 15138713
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional changes induced by epigenetic therapy with hydralazine and magnesium valproate in cervical carcinoma.
De la Cruz-Hernández E; Perez-Plasencia C; Pérez-Cardenas E; Gonzalez-Fierro A; Trejo-Becerril C; Chávez-Blanco A; Taja-Chayeb L; Vidal S; Gutiérrez O; Dominguez GI; Trujillo JE; Duenas-González A
Oncol Rep; 2011 Feb; 25(2):399-407. PubMed ID: 21152880
[TBL] [Abstract][Full Text] [Related]
17. Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptor.
Nishikawa K; Rosenblum MG; Newman RA; Pandita TK; Hittelman WN; Donato NJ
Cancer Res; 1992 Sep; 52(17):4758-65. PubMed ID: 1380890
[TBL] [Abstract][Full Text] [Related]
18. An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells.
Grant SL; Hammacher A; Douglas AM; Goss GA; Mansfield RK; Heath JK; Begley CG
Oncogene; 2002 Jan; 21(3):460-74. PubMed ID: 11821958
[TBL] [Abstract][Full Text] [Related]
19. Ascochlorin inhibits growth factor-induced HIF-1α activation and tumor-angiogenesis through the suppression of EGFR/ERK/p70S6K signaling pathway in human cervical carcinoma cells.
Jeong JH; Jeong YJ; Cho HJ; Shin JM; Kang JH; Park KK; Park YY; Chung IK; Chang HW; Magae J
J Cell Biochem; 2012 Apr; 113(4):1302-13. PubMed ID: 22109717
[TBL] [Abstract][Full Text] [Related]
20. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
